Fed-Fast Crossover Study to Assess the Effect of Food With CTx-1301 in Healthy Subjects (Fed-Fast)
An Open-label, Randomized, Single-dose, Two-period, Two-treatment (Fed vs Fasted), Two-sequence, Crossover Study in Healthy Adult Subjects to Assess the Effect of Food on the Absorption and Bioavailability of CTx-1301 (Dexmethylphenidate)
Sponsor: Cingulate Therapeutics
A PHASE1 clinical study on Healthy Volunteers in Fed and Fasted State, this trial is completed. The trial is conducted by Cingulate Therapeutics and has accumulated 14 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Nov 2022 — Jul 2024 [monthly]
Completed PHASE1
Status: Not Yet Recruiting → Completed
-
Sep 2022 — Nov 2022 [monthly]
Not Yet Recruiting PHASE1
-
Feb 2022 — Sep 2022 [monthly]
Not Yet Recruiting PHASE1
▶ Show 9 earlier versions
-
Sep 2021 — Feb 2022 [monthly]
Not Yet Recruiting PHASE1
-
Jun 2021 — Sep 2021 [monthly]
Not Yet Recruiting PHASE1
-
Apr 2021 — Jun 2021 [monthly]
Not Yet Recruiting PHASE1
-
Feb 2021 — Apr 2021 [monthly]
Not Yet Recruiting PHASE1
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting PHASE1
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE1
-
Sep 2020 — Nov 2020 [monthly]
Not Yet Recruiting PHASE1
-
Aug 2020 — Sep 2020 [monthly]
Not Yet Recruiting PHASE1
-
Jul 2020 — Aug 2020 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Cingulate Therapeutics
For direct contact, visit the study record on ClinicalTrials.gov .